Adaptive Biotechnologies Corp (ADPT) Stock Price, Quote & News

Company Profile

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a pat...

Industry: Biotechnology

Sector: Healthcare

Phone: 206 659 0067

Fax: 206 659 0667

Website: www.adaptivebiotech.com

Address:

1165 Eastlake Avenue East, Seattle, United States

Iightning Dec. 4 at 10:17 PM

1ightning® Premium Options Alert (Actionable) Ticker: $ADPT Contract: Dec 19 $12.5C Entry: 4.50 Exit: 6.85 Return: +52.30% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Iightning Dec. 4 at 5:58 AM

1ightning® Premium Options Alert (Actionable) Ticker: $ADPT Contract: Dec 19 $17.5C Entry: 1.48 Exit: 2.12 Return: +43.68% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

_www_larval_com_ Dec. 3 at 4:12 PM

Dufus here, $ADPT just reversed 3% higher to -5% (~1Mv) in the last few minutes, 12/19 options, follow for more volatility.

0 · Reply

medguy Dec. 3 at 4:00 PM

Looking for bounce $PSTG $ADPT $GTLB

0 · Reply

Iightning Dec. 2 at 12:14 AM

**1ightning® Premium Options Alert (Actionable)** **Ticker:** $ADPT **Contract:** Dec 19 $20C **Entry:** 0.71 **Exit:** 1.06 **Return:** **+48.90% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**

0 · Reply

WallStreetBuyDip Nov. 29 at 1:35 PM

Result summaries are very crucial to keep track of how the strategy is going. Here's track record showing the results for Small + Mid cap stocks. Will next trade $RXRX + $ADPT and more like I did for small + mid cap stocks when H% is low. Do you see why I only buy when H% is low? All include timestamps + buy fills for everything. The result speaks for itself.

0 · Reply

Gel021 Nov. 28 at 5:57 PM

$ADPT didn't enter adpt yet, just checked the post holiday's chart before the closure.. too risky for a short, same time too insane for a long.. prefer to wait.. xbi/ibb is down but it tells nothing.. will see the next month opening

0 · Reply

Iightning Nov. 26 at 3:06 AM

1ightning® Options Trade Alert (Actionable) | Buy $ADPT Dec 19 $22 Call | Enter: $0.52 Exit: $0.74 | Profit: 40.74% ROI | https://1ightning.com

0 · Reply

Gel021 Nov. 25 at 4:16 PM

$ADPT main purpose of the trading is opportunity to get in.. you must assume that the broker is the most involved part of manipulation (especially bio), so when you're trying to count your interest, try to find the brokerage interest first, its ways to manipulate a stock.. not pretend to be positive, still bearish.. yet very careful. a reversal might happens any minute

0 · Reply

Gel021 Nov. 25 at 2:48 PM

$ADPT Looks like a great candidate for a short position, but I'm not going to enter yet, looks like a short trap... Still consolidating and no gap... Probably better to get in after thxgiving... Happy holidays to holders and new buyers, will meet next monday if tomorrow won't be any bearish sign

0 · Reply

Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting

Nov 6, 2025, 4:05 PM EST - 4 weeks ago

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

Nov 6, 2025, 7:56 AM EST - 4 weeks ago

Adaptive Biotechnologies Corporation (ADPT) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 4:05 PM EST - 4 weeks ago

Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results

Oct 15, 2025, 4:05 PM EDT - 7 weeks ago

Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025

Sep 10, 2025, 3:58 PM EDT - 3 months ago

Adaptive Biotechnologies Corporation (ADPT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 27, 2025, 4:05 PM EDT - 3 months ago

Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 8, 2025, 6:05 AM EDT - 4 months ago

Aristotle Focus Growth Q2 Highlights: Top Performers, Surprises And Strategic Shifts

ASPS

Aug 6, 2025, 7:01 PM EDT - 4 months ago

Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday

Aug 6, 2025, 1:57 PM EDT - 4 months ago

Adaptive (ADPT) Q2 Revenue Surges 36%

Aug 6, 2025, 2:13 AM EDT - 4 months ago

Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 4:05 PM EDT - 4 months ago

Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results

Jul 15, 2025, 4:05 PM EDT - 5 months ago

Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025

Jul 1, 2025, 7:30 AM EDT - 5 months ago

Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®

May 30, 2025, 7:30 AM EDT - 6 months ago

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers

May 28, 2025, 4:05 PM EDT - 6 months ago

Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

May 1, 2025, 9:46 PM EDT - 7 months ago

Adaptive Biotechnologies Corporation (ADPT) Q1 2025 Earnings Call Transcript

May 1, 2025, 4:05 PM EDT - 7 months ago

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results

Apr 10, 2025, 4:05 PM EDT - 8 months ago

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025

Apr 8, 2025, 8:00 AM EDT - 8 months ago

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma

Mar 11, 2025, 8:00 AM EDT - 9 months ago

Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma

Feb 11, 2025, 7:47 PM EST - 10 months ago

Adaptive Biotechnologies Corporation (ADPT) Q4 2024 Earnings Call Transcript

Feb 11, 2025, 4:05 PM EST - 10 months ago

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results

Jan 22, 2025, 4:05 PM EST - 11 months ago

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025

Jan 14, 2025, 7:30 AM EST - 11 months ago

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

Jan 7, 2025, 7:30 AM EST - 11 months ago

Adaptive Biotechnologies Announces Clinical Lab Fee Schedule Rate of $2,007 for clonoSEQ® Test for Minimal Residual Disease Assessment is Effective as of January 1st, 2025

Jan 2, 2025, 4:05 PM EST - 1 year ago

Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 11, 2024, 6:55 AM EST - 1 year ago

Top 3 Health Care Stocks That May Collapse This Quarter

FNA NAMS

Dec 7, 2024, 6:30 PM EST - 1 year ago

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions

Dec 3, 2024, 7:30 AM EST - 1 year ago

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting

Nov 26, 2024, 10:53 AM EST - 1 year ago

Adaptive Biotechnologies: Making Some Progress

Nov 7, 2024, 9:57 PM EST - 1 year ago

Adaptive Biotechnologies Corporation (ADPT) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 7:30 AM EST - 1 year ago

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma

Oct 9, 2024, 4:05 PM EDT - 1 year ago

Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024

Aug 29, 2024, 7:30 AM EDT - 1 year ago

Adaptive Announces IVDR Certification for clonoSEQ® in European Union

Aug 22, 2024, 4:03 PM EDT - 1 year ago

Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 1, 2024, 10:25 PM EDT - 1 year ago

Adaptive Biotechnologies Corporation (ADPT) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 4:05 PM EDT - 1 year ago

Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results

Jul 11, 2024, 4:05 PM EDT - 1 year ago

Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024

May 31, 2024, 7:30 AM EDT - 1 year ago

Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

May 29, 2024, 4:05 PM EDT - 1 year ago

Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 8, 2024, 6:43 PM EDT - 1 year ago

Why Adaptive Biotechnologies Topped the Market Today

May 7, 2024, 8:59 PM EDT - 1 year ago

Adaptive Biotechnologies Corporation (ADPT) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 1 year ago

Adaptive Biotechnologies Reports First Quarter 2024 Financial Results

Apr 17, 2024, 4:05 PM EDT - 1 year ago

Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024

Apr 2, 2024, 4:05 PM EDT - 1 year ago

Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue

Mar 27, 2024, 8:30 AM EDT - 1 year ago

Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024

Feb 22, 2024, 4:05 PM EST - 1 year ago

Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference

Feb 14, 2024, 9:51 PM EST - 1 year ago

Adaptive Biotechnologies Corporation (ADPT) Q4 2023 Earnings Call Transcript

ANY

Feb 14, 2024, 4:05 PM EST - 1 year ago

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results

Iightning Dec. 4 at 10:17 PM

1ightning® Premium Options Alert (Actionable) Ticker: $ADPT Contract: Dec 19 $12.5C Entry: 4.50 Exit: 6.85 Return: +52.30% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Iightning Dec. 4 at 5:58 AM

1ightning® Premium Options Alert (Actionable) Ticker: $ADPT Contract: Dec 19 $17.5C Entry: 1.48 Exit: 2.12 Return: +43.68% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

_www_larval_com_ Dec. 3 at 4:12 PM

Dufus here, $ADPT just reversed 3% higher to -5% (~1Mv) in the last few minutes, 12/19 options, follow for more volatility.

0 · Reply

medguy Dec. 3 at 4:00 PM

Looking for bounce $PSTG $ADPT $GTLB

0 · Reply

Iightning Dec. 2 at 12:14 AM

0 · Reply

WallStreetBuyDip Nov. 29 at 1:35 PM

0 · Reply

Gel021 Nov. 28 at 5:57 PM

0 · Reply

Iightning Nov. 26 at 3:06 AM

1ightning® Options Trade Alert (Actionable) | Buy $ADPT Dec 19 $22 Call | Enter: $0.52 Exit: $0.74 | Profit: 40.74% ROI | https://1ightning.com

0 · Reply

Gel021 Nov. 25 at 4:16 PM

0 · Reply

Gel021 Nov. 25 at 2:48 PM

0 · Reply

Iightning Nov. 25 at 1:10 PM

1ightning® Options Trade Alert (Actionable) | Buy $ADPT Dec 19 $22 Call | Enter: $0.52 Exit: $0.74 | Profit: 40.74% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 25 at 2:05 AM

1ightning® Options Trade Alert (Actionable) | Buy $ADPT Dec 19 $22 Call | Enter: $0.52 Exit: $0.74 | Profit: 40.74% ROI | https://1ightning.com

0 · Reply

Gel021 Nov. 24 at 5:04 PM

$ADPT I already third day looking for an entry point to short, but cannot find a proper one.. do I miss something? there is a huge buyer, or this is a preparation for a bull trap?

1 · Reply

Treasury225 Nov. 24 at 3:58 PM

$ADPT WOW! Lot of fundamental and technical info to digest but a new price range for sure. I imagine there will be upgrades coming. Is that baked in???

0 · Reply

Iightning Nov. 21 at 11:21 PM

1ightning® Options Trade Alert (Actionable) | Buy $ADPT Dec 19 $15 Call | Enter: $1.57 Exit: $2.07 | Profit: 31.36% ROI | https://1ightning.com

0 · Reply

RunnerSignals Nov. 21 at 8:06 PM

$ADPT Heavy retail FOMO riding this momentum spike while it lasts

0 · Reply

WAJeff Nov. 21 at 6:01 PM

$ADPT 11/7 15.01s sold at 17 two weeks later

0 · Reply

Gel021 Nov. 21 at 4:58 PM

$ADPT what happened here? some positive news? is that worth its price?

3 · Reply

50bps Nov. 21 at 2:57 PM

$ADPT nice continuation

0 · Reply

Iightning Nov. 21 at 2:39 AM

1ightning® Options Trade Alert (Actionable) | Buy $ADPT Dec 19 $15 Call | Enter: $1.57 Exit: $2.07 | Profit: 31.36% ROI | https://1ightning.com

0 · Reply

Trader_Ty Nov. 21 at 2:14 AM

$ADPT

0 · Reply

RunnerSignals Nov. 20 at 9:18 PM

$WMT $ADPT $GRI $NUTX $CPRI breaking free from sideways snooze mode today and some moves are sizzling, some need a watchful eye

0 · Reply

Market Cap	2.85B
Revenue (ttm)	178.96M
Net Income (ttm)	-159.49M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-89.12%
Debt to Equity Ratio	0.00

Volume	2,928,000
Avg Vol	2,093,360
Day's Range	N/A - N/A
Shares Out	152.67M
Stochastic %K	30%
Beta	2.20
Analysts	Strong Sell
Price Target	$20.29